Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

ALTEX

Showing results (211-220 of 1,366) with videos related to

Pageof 137
Sort By:
ALTEX|April 13, 2010
Long term cultures of primary human hepatocytes as an alternative to drug testing in animalsAnett Ullrich, Donna B Stolz, Ewa C Ellis, et al.
ALTEX|December 2, 2011
How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?Costanza Rovida, Fabiola Longo, Richard R Rabbit
ALTEX|December 2, 2011
Critical evaluation of the use of dogs in biomedical research and testing in EuropeNina Hasiwa, Jarrod Bailey, Peter Clausing, et al.
ALTEX|December 2, 2011
Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture mediaCaroline Rauch, Elisabeth Feifel, Eva-Maria Amann, et al.
ALTEX|December 2, 2011
Assessment of stress in laboratory beagle dogs constrained by a Pavlov slingJenny Stracke, Bettina Bert, Heidrun Fink, et al.
ALTEX|October 14, 2011
Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept caseJoanna Jaworska, Artsiom Harol, Petra S Kern, et al.
ALTEX|October 14, 2011
Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albuminRolando Perdomo-Morales, Zenia Pardo-Ruiz, Ingo Spreitzer, et al.
ALTEX|February 7, 2012
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testingDavid A Basketter, Harvey Clewell, Ian Kimber, et al.
ALTEX|June 1, 2011
Examining the regulatory value of multi-route mammalian acute systemic toxicity studiesTroy Seidle, Pilar Prieto, Anna Bulgheroni
ALTEX|October 14, 2011
t⁴ workshop report. Nanotoxicology: "the end of the beginning" - signs on the roadmap to a strategy for assuring the safe application and use of nanomaterialsEllen K Silbergeld, Elizabeth Q Contreras, Thomas Hartung, et al.
Pageof 137

Showing results (211-220 of 1,366) with videos related to

Sort By:
Pageof 137
ALTEX|April 13, 2010
Long term cultures of primary human hepatocytes as an alternative to drug testing in animalsAnett Ullrich, Donna B Stolz, Ewa C Ellis, et al.
ALTEX|December 2, 2011
How are reproductive toxicity and developmental toxicity addressed in REACH dossiers?Costanza Rovida, Fabiola Longo, Richard R Rabbit
ALTEX|December 2, 2011
Critical evaluation of the use of dogs in biomedical research and testing in EuropeNina Hasiwa, Jarrod Bailey, Peter Clausing, et al.
ALTEX|December 2, 2011
Alternatives to the use of fetal bovine serum: human platelet lysates as a serum substitute in cell culture mediaCaroline Rauch, Elisabeth Feifel, Eva-Maria Amann, et al.
ALTEX|December 2, 2011
Assessment of stress in laboratory beagle dogs constrained by a Pavlov slingJenny Stracke, Bettina Bert, Heidrun Fink, et al.
ALTEX|October 14, 2011
Integrating non-animal test information into an adaptive testing strategy - skin sensitization proof of concept caseJoanna Jaworska, Artsiom Harol, Petra S Kern, et al.
ALTEX|October 14, 2011
Monocyte activation test (MAT) reliably detects pyrogens in parenteral formulations of human serum albuminRolando Perdomo-Morales, Zenia Pardo-Ruiz, Ingo Spreitzer, et al.
ALTEX|February 7, 2012
A roadmap for the development of alternative (non-animal) methods for systemic toxicity testingDavid A Basketter, Harvey Clewell, Ian Kimber, et al.
ALTEX|June 1, 2011
Examining the regulatory value of multi-route mammalian acute systemic toxicity studiesTroy Seidle, Pilar Prieto, Anna Bulgheroni
ALTEX|October 14, 2011
t⁴ workshop report. Nanotoxicology: "the end of the beginning" - signs on the roadmap to a strategy for assuring the safe application and use of nanomaterialsEllen K Silbergeld, Elizabeth Q Contreras, Thomas Hartung, et al.
Pageof 137